MORGAN STANLEY - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$286,437
-25.8%
124,538
+17.7%
0.00%
Q2 2023$386,218
+9.4%
105,813
+7.0%
0.00%
Q1 2023$353,162
-30.7%
98,925
-44.7%
0.00%
Q4 2022$509,570
-10.4%
178,796
-30.0%
0.00%
Q3 2022$569,000
-47.6%
255,308
-41.4%
0.00%
Q2 2022$1,085,000
+12.0%
435,582
+119.3%
0.00%
Q1 2022$969,000
-51.6%
198,579
+12.3%
0.00%
Q4 2021$2,000,000
-71.1%
176,819
-62.7%
0.00%
-100.0%
Q3 2021$6,910,000
+38.8%
474,231
+11.0%
0.00%0.0%
Q2 2021$4,978,000
+27.8%
427,355
+33.9%
0.00%0.0%
Q1 2021$3,894,000
-42.8%
319,119
-41.3%
0.00%0.0%
Q4 2020$6,806,000
+87.6%
544,062
+125.7%
0.00%0.0%
Q3 2020$3,628,000
+7.5%
241,067
+75.1%
0.00%0.0%
Q2 2020$3,375,000
+507.0%
137,707
+251.3%
0.00%
Q1 2020$556,000
-53.9%
39,202
-48.4%
0.00%
Q4 2019$1,207,000
+402.9%
76,028
+166.6%
0.00%
Q3 2019$240,000
+22.4%
28,515
+31.2%
0.00%
Q2 2019$196,000
+21.0%
21,726
+3.4%
0.00%
Q1 2019$162,000
-28.9%
21,008
-56.7%
0.00%
Q4 2018$228,000
-68.6%
48,537
-39.3%
0.00%
Q3 2018$725,000
+49.8%
80,024
+96.1%
0.00%
Q2 2018$484,000
+48.0%
40,812
+75.1%
0.00%
Q1 2018$327,00023,3070.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders